• Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
Tuesday, February 7, 2023
No Result
View All Result
SUBSCRIBE
The Outlooker
27 °c
Delhi
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
No Result
View All Result
The Outlooker
No Result
View All Result
  • National
  • Politics
  • Opinion
  • Business
  • Science
  • World
  • Health
Home National

Bharat Biotech Seeks Emergency Use Approval For Coronavirus Vaccine Covaxin

by The Outlooker Web Desk
December 7, 2020
in National
0
Bharat Biotech Seeks Emergency Use Approval For Coronavirus Vaccine Covaxin
1.8k
SHARES
12.9k
VIEWS
Share on FacebookShare on Twitter

Covaxin is being indigenously developed by Bharat Biotech

New Delhi:

Bharat Biotech, the Hyderabad-based pharmaceutical firm that has been developing coronavirus vaccine Covaxin, today said that it had applied to the central drug regulator seeking emergency use authorisation.

It is the third firm after Serum Institute of India and American pharma giant Pfizer to apply for emergency use approval.

Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and is currently in Phase 3 trials. The trials are on at 18 sites across the country with over 22,000 volunteers.

An emergency use approval of a drug can be granted after there is sufficient evidence to suggest that the medical product is safe and effective. Final approval is granted only after completion of the trials and analysis of full data.

An emergency authorisation is also granted in situations like the present when the entire world has been grappling with the coronavirus pandemic that has affected millions across the globe and killed over 1.5 million. In such situations, regulatory authorities around the world use this mechanism to grant interim approvals to drugs.

The emergency use authorisation will allow the vaccine to be administered to people under certain conditions – for a limited period of time or on specific groups.

Newsbeep

On December 4, Prime Minister Narendra Modi at an all-party meeting had expressed hope that a COVID-19 vaccine may be ready in a few weeks.

On the same say, the Indian arm of Pfizer sought emergency use approval for its vaccine from the central drug regulator, after the firm secured such clearance in the UK and Bahrain.

The Serum Institute has also asked for the approval for the Oxford COVID-19 vaccine, Covishield, on December 6.

The applications of Bharat Biotech, Serum Institute of India and Pfizer will be reviewed by the subject expert committee (SEC) on COVID-19 at the Central Drugs Standard Control Organisation (CDSCO) in the coming days.

(If you like reading The Outlooker, please consider subscribing to us below. Subscriptions are free for first 500 subscribers.)

The Outlooker Web Desk

The Outlooker Web Desk

Next Post
Haryana Farmers’ Groups Break Ranks, Say Okay With Amended Farm Laws

Haryana Farmers' Groups Break Ranks, Say Okay With Amended Farm Laws

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Rahul Gandhi Expresses Grief Over Loss Of Lives
National

Rahul Gandhi Expresses Grief Over Loss Of Lives

February 6, 2023
2 Soldiers Die As T-90 Tank Barrel Explodes During Firing Exercise In UP
National

In 2022-2023, Defence Expenditure Was 14.08% Of Expenses: Centre

February 6, 2023
“Who Is Shah Rukh Khan?” Assam’s Himanta Sarma When Asked About Pathaan
National

Teenage Pregnancy Ratio In State Quite Alarming, Says Assam Chief Minister Himanta Biswa Sarma

February 6, 2023
Congress Tripura manifesto promises old pension scheme, free 150 units of electricity
Politics

Congress Tripura manifesto promises old pension scheme, free 150 units of electricity

February 6, 2023

Connect with us

No Result
View All Result

Archives

  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020

Category

  • Artistic
  • Business
  • Crypto
  • Design
  • Entertainment
  • Fashion
  • featured
  • Food
  • Gaming
  • Health
  • Human
  • Lifestyle
  • Movie
  • Music
  • National
  • Opinion
  • Politics
  • Science
  • Spaces
  • Sports
  • Tech
  • Travel
  • Uncategorized
  • World

Recent Posts

  • Rahul Gandhi Expresses Grief Over Loss Of Lives
  • In 2022-2023, Defence Expenditure Was 14.08% Of Expenses: Centre
  • Teenage Pregnancy Ratio In State Quite Alarming, Says Assam Chief Minister Himanta Biswa Sarma

About Us

The Outlooker

The Outlooker is your source of authentic, hand-picked news, stories, analysis from India & the World.

  • Terms Of Service
  • Privacy Policy
  • About us
  • Submit your story
  • Contact

© 2019-2021 The Outlooker. All rights reserved.

No Result
View All Result
  • Home
  • Politics
  • World
  • Business
  • Science
  • National
  • Entertainment
  • Gaming
  • Movie
  • Music
  • Sports
  • Fashion
  • Lifestyle
  • Travel
  • Tech
  • Health
  • Food

© 2019-2021 The Outlooker. All rights reserved.